Suven Life Sciences Ltd.
Snapshot View

61.80 -2.40 ▼-3.7%

27 January 2023, 04:01:00 PM
Volume: 10,481

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.suven.com
Market Cap 1,349.88 Cr.
Enterprise Value(EV) 1,380.67 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -4.31 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-09
Industry PE 32.90 Trailing Twelve Months Ending 2022-09
Book Value / Share 20.92 Trailing Twelve Months Ending 2022-09
Price to Book Value 2.95 Calculated using Price: 61.80
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 21.81 Cr. 218,073,717 Shares
FaceValue 1
Company Profile
Suven Life Sciences was promoted by Mrs. and Mr. Venkat Jasti in 1989, as a Private Limited Company. Later it was converted into a Public Limited Company in January 1995.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-3.74%
1 Week
-5.58%
1 Month
-8.31%
3 Month
-0.24%
6 Month
-4.17%
1 Year
-24.25%
2 Year
-7.98%
5 Year
-68.81%
10 Year
+154.53%
9 years 2008-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 8.04 32.91 12.50 13.81 17.25 -4.75 -49.27 -67.29 -145.90
Return on Capital Employed (%) 7.51 37.93 15.43 18.19 26.01 0.40 -54.67 -60.09 -117.81
Return on Assets (%) 4.49 22.38 8.87 9.97 12.84 -3.31 -27.07 -28.99 -57.51

Balance Sheet View Details >>

Particulars 9 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 559 595 667 767 239 143 108 96 56
Non Curr. Liab. 86 41 28 30 25 12 5 4 4
Curr. Liab. 127 211 208 226 157 120 110 102 61
Minority Int.
Equity & Liab. 773 846 903 1,023 421 275 222 202 121
Non Curr. Assets 291 319 322 350 22 116 26 41 40
Curr. Assets 477 528 581 674 398 160 197 160 80
Misc. Exp. not W/O 5
Total Assets 773 846 903 1,023 421 275 222 202 121

Profit Loss View Details >>

Particulars 10 years 2008-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 117 521 500 544 625 286 14 13 12 17
Other Income 3 9 20 21 23 27 14 8 5 1
Total Income 120 529 519 565 649 313 28 21 17 17
Total Expenditure -105 -361 -398 -414 -424 -297 -130 -93 -134 -112
PBIDT 16 168 121 150 225 16 -102 -72 -117 -94
Interest -5 -5 -6 -6 -5 -2 -1 -1 -1 0
Depreciation -4 -12 -18 -21 -25 -14 -4 -4 -4 -6
Taxation 2 -43 -26 -36 -72 -24 12 5
Exceptional Items 6
PAT 8 109 72 87 124 -24 -94 -72 -122 -94
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 8 109 72 87 124 -24 -94 -72 -122 -94
Adjusted EPS 1 8 5 6 9 -2 -7 -5 -8 -6

Cash Flow View Details >>

Particulars 8 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 143 68 109 70 -53 -135 -96 -128
Cash Fr. Inv. -110 -39 -311 -1 37 146 56 -22
Cash Fr. Finan. 179 -68 -30 -52 5 3 35 146
Net Change 212 -39 -232 17 -11 14 -5 -4
Cash & Cash Eqvt 279 241 9 26 0 15 9 5

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 60.00 60.00 60.00 60.00 60.00 64.98 64.98 64.98 69.57
Public 40.00 40.00 40.00 40.00 40.00 35.02 35.02 35.02 30.43
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Wed, 25 Jan 2023
Board Meeting Intimation for Intimation Of Board Meeting Of The Company To Be Held On Thursday February 02 2023 - Reg.
SUVEN LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2023 inter alia to consider and approve With reference to above subject pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please note that a Meeting of the Board of Directors of the Company will be held on Thursday February 02 2023 at 11:30 a.m. at the Registered Office of the Company at SDE Serene Chambers 6th Floor Road No 5 Banjara Hills Hyderabad-500034 to consider among other things inter alia and take on record the following matter(s): To consider and approve the Un-audited Financial Results (Standalone and Consolidated) of the Company under Ind AS for the quarter ended December 31 2022 and related matters.Please further note that TRADING WINDOW for dealing in the securities of the company is already closed from January 01 2023 as per PIT Code of the Company. Trading window will be opened from February 06 2023.
Fri, 06 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
This is to inform that the details of securities dematerialized/ rematerialized during the quarter ended December 31 2022 as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 have been furnished by KFin Technologies Limited Registrar & Transfer Agent (RTA) of the Company to the stock exchanges where the shares of the Company are listed. Letters confirming this from KFin Technologies Limited dated January 06 2023 are enclosed for your reference.
Fri, 30 Dec 2022
Closure of Trading Window
We wish to inform that the "Trading Window" for dealing in the securities of the Company will be closed for the Designated Persons their immediate relatives covered under the said Code of the Company from January 01 2023 and the same will remain closed till 48 hours after the declaration of Financial Results for the quarter ending December 31 2022 to the public in terms of the Code of Conduct of the Company under the SEBI (Prohibition of Insider Trading) Regulations 2015.

Technical Scans View Details >>

Fri, 27 Jan 2023
Close Crossing Last Week Low Close Crossing Last Week Low
Closing Below Previous Low Closing Below Previous Low
Making Lower Lows for 3 days Making Lower Lows for 3 days
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
Close Below Last Week Low Close Below Last Week Low

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 249,710.79 1,040.75 +0.1%
Divi's Laboratories Ltd. 89,875.72 3,385.55 +1.5%
Cipla Ltd. 84,895.40 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. 71,960.69 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. 61,265.20 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. 52,047.83 1,537.85 -1.3%
Abbott India Ltd. 45,216.39 21,279.00 0.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.84 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 30.03 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-12 32.18 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.75 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.97 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.63 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 51.28 21,279.00 0.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.70 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 7.41 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-12 3.74 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.27 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.24 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.17 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 16.66 21,279.00 0.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 0.00 21,279.00 0.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 4,919.27 21,279.00 0.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 798.70 21,279.00 0.0%

FAQ's On Suven Life Sciences Ltd.

What is Suven Life Sciences share price?

Can I buy Suven Life Sciences shares now?

What is the Market Cap of Suven Life Sciences?

What are the key metrics to analyse Suven Life Sciences?

What is the 52 Week High and Low of Suven Life Sciences?

What is the trend of Suven Life Sciences share price?